Oral Wegovy (the semaglutide pill): what the data and price really show
The first weight-loss GLP-1 you swallow arrived in January 2026. What OASIS 4 found, how the pill compares to the injection, and what it costs.
The first weight-loss GLP-1 you swallow
For its entire modern history, effective GLP-1 weight-loss therapy meant a weekly injection. That changed in December 2025, when the FDA approved the Wegovy pill — once-daily oral semaglutide 25 mg — the first oral GLP-1 receptor agonist cleared for chronic weight management. Novo Nordisk began the US launch in early January 2026. It is the same molecule as injectable Wegovy, delivered as a daily tablet rather than a weekly shot, and it carries the same active-ingredient indication to reduce weight and, for eligible patients with established cardiovascular disease, to lower the risk of major adverse cardiovascular events.
What the OASIS 4 trial showed
The approval rests on the phase 3 OASIS 4 trial, a 64-week study of 307 adults with obesity or overweight-plus-comorbidity, without diabetes. Participants taking the 25 mg pill lost about 16.6% of body weight when they stayed fully on treatment, versus about 2.7% on placebo; measured regardless of whether people stayed on treatment, the figure was about 13.6% versus 2.4%. Roughly one in three fully-adherent participants lost 20% or more. That places the pill in the same broad range as injectable Wegovy 2.4 mg, which is the headline reason the approval mattered.
Pill vs injection: the real trade-offs
The two forms share a molecule but differ in practical ways that matter day to day. The pill is taken once daily on an empty stomach with a small sip of water, followed by a 30-minute wait before eating, drinking, or other medications — a real adherence demand the injection doesn't impose. The injection is weekly and must be refrigerated; the pill needs no refrigeration and suits people who dislike needles or travel often. Side effects are similar — gastrointestinal symptoms dominate both, concentrated during dose escalation — and both carry the boxed thyroid warning. The choice is less about efficacy than about which routine you'll actually stick to.
| Attribute | Wegovy pill (oral) | Wegovy injection |
|---|---|---|
| Frequency | Once daily | Once weekly |
| Administration | Empty stomach, 30-min wait | Any time, with/without food |
| Storage | No refrigeration | Refrigerated |
| Trial weight loss | ~16.6% (adhered) | ~14.9% (STEP 1) |
| Self-pay start price | ~$149/mo | ~$199 intro, then ~$349/mo |
What the Wegovy pill costs
Novo Nordisk set the pill's self-pay price at about $149/month for the 1.5 mg starting dose, with insured copays potentially $25 or less. Higher maintenance doses cost more through some channels. That entry price undercuts a lot of the brand injection market and lands close to transparent compounded flat-rate programs — a meaningful shift, because it's an FDA-approved product at a price that finally competes with the cash-pay compounded market on the low end.
Who the pill suits — and who it doesn't
The pill is a strong fit for people who avoid or dislike injections, travel frequently, or want an FDA-approved product at a lower entry price than the brand injection historically offered. It's a weaker fit for anyone who struggles with the strict empty-stomach dosing window, since absorption depends on it and inconsistent timing undercuts the result. For cost-focused cash-pay patients, the pill's ~$149 entry price now sits alongside transparent flat-rate compounded options — though compounded semaglutide is not FDA-approved, while the pill is. As always, which product and dose fit you is a clinical decision for your prescriber.
Frequently asked questions
Is there a semaglutide pill for weight loss?
Yes. The FDA approved the Wegovy pill (once-daily oral semaglutide 25 mg) in December 2025, launched in the US in early January 2026 — the first oral GLP-1 approved for chronic weight management. It is distinct from Rybelsus, the older oral semaglutide approved for type 2 diabetes.
How much weight do you lose on the Wegovy pill?
In the OASIS 4 trial, adults lost about 16.6% of body weight when fully adherent (13.6% regardless of adherence) over 64 weeks, versus about 2.7% on placebo — similar to injectable Wegovy.
How much does the Wegovy pill cost?
Novo Nordisk set the self-pay price near $149/month for the 1.5 mg starting dose; insured copays may be $25 or less. Higher doses can cost more through some channels.
Is the Wegovy pill as good as the injection?
In trials, the pill produced similar weight loss to the injection. The main differences are practical: daily empty-stomach dosing with a 30-minute wait, no refrigeration, and no needles. Suitability is a clinical decision.
Do I take the Wegovy pill with food?
No. It's taken once daily on an empty stomach with a small sip of water, followed by a 30-minute wait before eating, drinking, or other medications. Consistent timing is essential for absorption.
References
- Novo Nordisk. FDA approves Wegovy pill (oral semaglutide 25 mg). News release, December 22, 2025.
- Wharton S, et al. OASIS 4: Oral semaglutide 25 mg in adults with overweight or obesity. 2025.
- U.S. FDA. Wegovy (semaglutide) tablets prescribing information, 2025.
- WeightLoss GLP-1 July 2026 price report.
Clinical and regulatory figures from published trials, FDA, and CMS communications; pricing from provider-advertised and manufacturer rates checked July 2026 and subject to change. Educational, not medical or financial advice.